Issued Patents All Time
Showing 25 most recent of 57 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12268663 | Method for treating pruritus | Eric Carlson | 2025-04-08 |
| 9765340 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2017-09-19 |
| 9745585 | RNAi-mediated inhibition of histamine receptor H1-related conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2017-08-29 |
| 9453220 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders | John E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2016-09-27 |
| 9447419 | RNAi-mediated inhibition of tumor necrosis factor α-related conditions | Jon E. Chatterton, Diane Michelle Senchyna, Daniel A. Gamache, Steven T. Miller | 2016-09-20 |
| 9371529 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2016-06-21 |
| 9206428 | RNAi-mediated inhibition of histamine receptor H1-related conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2015-12-08 |
| 8993636 | Compositions containing moxifloxacin for treating otic infections | Gerald D. Cagle, Robert L. Abshire, David W. Stroman | 2015-03-31 |
| 8865671 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2014-10-21 |
| 8673902 | Method of treating otic infections with moxifloxacin compositions | Gerald D. Cagle, Robert L. Abshire, David W. Stroman | 2014-03-18 |
| 8673873 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2014-03-18 |
| 8618278 | RNAi-mediated inhibition of histamine receptor H1-related conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2013-12-31 |
| 8541389 | RNAi-mediated inhibition of tumor necrosis factor α-related conditions | Jon E. Chatterton, Diane Michelle Senchyna, Daniel A. Gamache, Steven T. Miller | 2013-09-24 |
| 8222227 | RNAi-mediated inhibition of histamine receptor H1-related conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2012-07-17 |
| 8138205 | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 | Steven P. Govek, Clay Beauregard, Daniel A. Gamache, Mark R. Hellberg, Stewart A. Noble +2 more | 2012-03-20 |
| 8048863 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2011-11-01 |
| 8017592 | RNAi-mediated inhibition of histamine receptor H1-related conditions | Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller | 2011-09-13 |
| 7732421 | RNAI-mediated inhibition of tumor necrosis factor α-related conditions | Jon E. Chatterton, Diane Michelle Senchyna, Daniel A. Gamache, Steven T. Miller | 2010-06-08 |
| 7671070 | Method of treating ophthalmic infections with moxifloxacin compositions | Gerald D. Cagle, Robert L. Abshire, David W. Stroman | 2010-03-02 |
| 6872382 | Use of selective PDE IV inhibitors to treat dry eye disorders | Daniel A. Gamache | 2005-03-29 |
| 6740664 | Methods for treating otic and ophthalmic infections | Gerald D. Cagle, Robert L. Abshire, David W. Stroman, Celeste H. McLean, Linda L. Clark | 2004-05-25 |
| 6716830 | Ophthalmic antibiotic compositions containing moxifloxacin | Gerald D. Cagle, Robert L. Abshire, David W. Stroman | 2004-04-06 |
| 6696453 | Use of NF-&kgr;B inhibitors to treat dry eye disorders | Daniel A. Gamache | 2004-02-24 |
| 6649602 | Use of an H1 antagonist and a safe steroid to treat eye conditions | — | 2003-11-18 |
| 6645978 | Lipoxin A4 and its analogs for the treatment of dry eye | Daniel A. Gamache, Gustav Graff, Mark R. Hellberg, Peter G. Klimko | 2003-11-11 |